Molefy Pharma launches new website to share breakthrough progress in ALS research and drug development
Santa Cruz de Tenerife, 9 de junio de 2025. Molefy Pharma, a biotech company born from the collaboration between ARQUIMEA and CSIC, has announced the launch of its new corporate website www.molefypharma.com , a platform designed to offer comprehensive insight into the company’s mission, scientific research, and advancements in the development of innovative treatments for […]